Linda Palczuk

Linda Palczuk

Director/Board Member at AVADEL PHARMACEUTICALS PLC

Net worth: 669 672 $ as of 2024-02-28

62 year
Health Technology
Consumer Services

Profile

Linda S.
Palczuk
is Chief Operating Officer for Envara Health, Inc. She is also on the board of Avadel Pharmaceuticals Plc.
She previously occupied the position of Chief Operating Officer for Verrica Pharmaceuticals, Inc., President & Chief Executive Officer of Osiris Therapeutics, Inc. and Vice President-Sales & Marketing of AstraZeneca Pharmaceuticals LP.
Linda S.
Palczuk
received an undergraduate degree from Franklin & Marshall College and an MBA from Alfred Lerner College of Business & Economics.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-08-31 52,400 ( 0.06% ) 669 672 $ 2024-02-28

Linda Palczuk active positions

CompaniesPositionStart
AVADEL PHARMACEUTICALS PLC Director/Board Member 2018-06-30
Chief Operating Officer 2018-12-31
All active positions of Linda Palczuk

Former positions of Linda Palczuk

CompaniesPositionEnd
VERRICA PHARMACEUTICALS INC. Chief Operating Officer 2019-04-21
OSIRIS THERAPEUTICS, INC. Chief Executive Officer 2018-02-08
Sales & Marketing 2015-02-28
See the detail of Linda Palczuk's experience

Training of Linda Palczuk

Franklin & Marshall College Undergraduate Degree
Alfred Lerner College of Business & Economics Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Linda Palczuk's experience

Connections

48

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
VERRICA PHARMACEUTICALS INC.

Health Technology

AVADEL PHARMACEUTICALS PLC

Health Technology

Private companies3

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Linda Palczuk